What is Translational Science?

We are proud to be part of the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award (CTSA) Program. This collaborative effort, involving more than 60 academic research institutes, is dedicated to improving the process of translational research. Our latest CTSA grant, awarded in 2023 for a term of seven years, entrusts MICHR with accelerating the development of health solutions through translational science.

According to the NIH, “translational science is the field that generates scientific and operational innovations that overcome longstanding challenges along the translational research pipeline. These include scientific, operational, financial, and administrative innovations that transform the way that research is done, making it faster, more efficient, and more impactful.”

Translational scientists examine the translational research ecosystem at a systems level to determine where common pitfalls exist in the translational process and to develop solutions that will ultimately benefit research across a range of diseases and conditions.

At MICHR, our innovative offerings and partnerships strive to address health disparities and deliver the benefits of translational science to all. We’re exploring persistent problems, creating novel solutions, showing how they work, and then sharing them widely. We’re also developing strong collaborations locally and nationally to ensure we are solving the right problems with the right voices at the table. Our goal is for the solutions we develop to be informed by the people who will use them.

With these initiatives and a mindset of creativity and experimentation, we are improving the process of translational research to deliver more health solutions to all people more quickly.